Gastric Electrical Stimulators Gathering Steam as Clinical Intervention for Patients with Gastroparesis

Gastric electrical stimulators (GES) is emerging as a popular clinical intervention for patients with gastroparesis. Particularly, the health care industry has been attaching marked clinical preference for gastric electric stimulation for recalcitrant gastroparesis. Findings of a growing body of recent studies highlight diabetic etiology and nausea as the predominant symptoms in GES. New technological developments in the mechanism of action of GES stem from the growing role of such minimally-invasive surgical interventions in improving the quality of life of patients. Over the past few decades, there have been numerous single-center studies to assess the role of electrical stimulation in gastroparesis. The fact that gastric electrical stimulation is reversible has made it popular among patients.

Get Sample Copy of this Report @

Growing clinical expertise of minimally invasive surgery for gastroparesis in healthcare centers, notably in clinics, is a key dynamic to the demand for gastric electrical stimulators. Advances in technologies pertaining to endoscopically delivered gastric electrical stimulation have expanded the prospect of the GES market.

Advances in Implantation Techniques Boosts Surgical Outcomes

Patients with clinically severe gastroparesis are expected to benefit from this surgical therapy to avoid conditions of malnutrition and dehydration. Over the past few years, despite significant improvements its use has brought to the life of the affected, a few side-effects remain unexplained. Hence, the gastric electrical stimulators market is expected to benefit from adopting a pre-operative identification of patients that are the best candidate for the surgery. Advances in implantation techniques have improved surgical outcomes, catalyzing the outlook of the market.

Check Table of Contents of this Report @

Among the various geographies, Europe is a prominent market. Its growth is driven by the presence of large patient population with gastroparesis that defies conservative medical management. The U.S. is a substantially lucrative country market. Focus on advancements in implantation technology boosts prospect of the regional market.